Clearside Biomedical, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Clearside Biomedical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Clearside Biomedical, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.93M, a 15.9% increase year-over-year.
  • Clearside Biomedical, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24.6M, a 17.8% increase year-over-year.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2023 was -$24.8M, a 17.9% increase from 2022.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2022 was -$30.3M, a 4729% decline from 2021.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2021 was -$627K, a 96.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$24.8M +$5.43M +17.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$30.3M -$29.7M -4729% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 -$627K +$17.3M +96.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 -$17.9M +$12.4M +40.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 -$30.3M +$52.6M +63.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 -$82.9M -$24.5M -42% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 -$58.4M -$33.2M -132% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 -$25.2M -$7.88M -45.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 -$17.3M -$7.49M -76.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 -$9.82M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.